巨噬细胞移动抑制因子与脓毒症心肌损伤相关标志物的相关性分析及其预后预测价值
前瞻性观察研究纳入63例成人脓毒症患者,按入ICU首日cTnI≥0.04 μg/L分为SIMI组(23例)与非SIMI组(40例)。SIMI组APACHE II评分、ALT、AST、NT-proBNP、cTnI、CK-MB、IL-18及MIF均高于非SIMI组。MIF与IL-18、APACHE II评分正相关,与LVEF负相关。MIF联合IL-18预测28天死亡的AUC为0.784,敏感度78.6%、特异度79.6%;基于SOFA评分、IL-18、MIF及氧合指数构建的列线图模型AUC为0.894。
要点
- 脓毒症合并心肌损伤(cTnI≥0.04 μg/L)患者入ICU 24小时内MIF、IL-18、NT-proBNP、CK-MB均显著高于无心肌损伤者。
- MIF与IL-18(r=0.523)、APACHE II评分(r=0.556)正相关,与LVEF负相关(r=-0.265),提示MIF可辅助早期识别SIMI。
- MIF预测28天死亡AUC 0.745(95%CI 0.563-0.933),IL-18为0.751(95%CI 0.614-0.892),两者联合AUC 0.784(95%CI 0.629-0.940)。
- 多因素分析显示SOFA评分升高(OR=1.381,95%CI 1.067-1.787,P=0.014)、IL-18升高(OR=1.000,P=0.023)、MIF升高(OR=1.000,P=0.036)、氧合指数降低(OR=0.989,95%CI 0.978-1.000,P=0.046)为28天死亡独立危险因素。
- 基于上述4项变量构建的列线图模型预测28天死亡AUC 0.894(95%CI 0.766-1.000),校准曲线与DCA示判别力、校准度及临床效用良好。
适用人群与场景
- 连续纳入2024年7月至2025年6月新疆医科大学第一附属医院重症医学科收治的63例确诊成人脓毒症患者。
- 按入ICU首日cTnI水平分组:SIMI组(cTnI≥0.04 μg/L,23例)与非SIMI组(cTnI<0.04 μg/L,40例)。
诊断标准与关键阈值
- 脓毒症心肌损伤(SIMI)判定标准:入ICU首日cTnI≥0.04 μg/L;cTnI<0.04 μg/L为脓毒症无心肌损伤。
- 疾病严重程度采用入ICU 24小时内APACHE II评分与SOFA评分评估。
- 预后预测模型变量:SOFA评分、IL-18、MIF、氧合指数。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性观察研究,单中心,样本量63例(SIMI组23例、非SIMI组40例)。
- SIMI组APACHE II评分、ALT、AST、NT-proBNP、cTnI、CK-MB、IL-18、MIF均高于非SIMI组(均P<0.05);人口学资料、其他实验室指标及超声心动图参数两组差异无统计学意义。
- MIF与IL-18(r=0.523)、APACHE II评分(r=0.556)正相关(均P<0.05);MIF与LVEF负相关(r=-0.265,P<0.05),与左室舒张末后壁厚度、左房舒张末内径无显著相关(均P>0.05)。
- MIF预测28天死亡AUC 0.745(95%CI 0.563-0.933);IL-18 AUC 0.751(95%CI 0.614-0.892);两者联合AUC 0.784(95%CI 0.629-0.940),敏感度78.6%、特异度79.6%。
- 多因素Logistic回归:SOFA评分升高OR=1.381(95%CI 1.067-1.787,P=0.014)、IL-18升高OR=1.000(95%CI 1.000-1.001,P=0.023)、MIF升高OR=1.000(95%CI 1.000-1.000,P=0.036)、氧合指数降低OR=0.989(95%CI 0.978-1.000,P=0.046)为28天死亡独立危险因素。
- 列线图模型预测28天死亡AUC 0.894(95%CI 0.766-1.000),C-index 0.894,校准曲线与DCA示良好判别力、校准能力及临床效用。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察性研究。
- 局限:样本量小(63例),单中心,观察性设计,模型需外部验证;原文未给出证据等级或推荐强度。
对床旁实践的改变
- 对脓毒症患者,入ICU 24小时内检测MIF与IL-18可辅助早期识别心肌损伤并提升28天死亡风险预测,尤其联合cTnI、SOFA评分及氧合指数综合评估。
- MIF与IL-18联合预测的AUC(0.784)高于任一单项,但该结果来自单中心小样本观察性研究,尚不能作为独立决策阈值推广至全部脓毒症人群。
- 列线图模型(含SOFA评分、IL-18、MIF、氧合指数)AUC达0.894,可用于风险分层辅助,但需外部验证后方可在床旁常规使用;原文未提及具体干预措施或治疗调整方案。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the association between macrophage migration inhibitory factor (MIF) and sepsis-induced myocardial injury (SIMI), as well as its predictive value for the prognosis of septic patients.
METHODS: A prospective observational study was conducted. Sixty-three adult patients with confirmed sepsis admitted to the department of critical care medicine of The First Affiliated Hospital of Xinjiang Medical University from July 2024 to June 2025 were consecutively enrolled. According to the cardiac troponin I (cTnI) level on the first day of admission, the patients were divided into SIMI group (cTnI≥0.04 μg/L) and sepsis without myocardial injury group (cTnI<0.04 μg/L). The demographic data, admission-related scores, and laboratory indicators of septic patients, measured indicators such as MIF and interleukin-18 (IL-18) within 24 hours of patients' admission to the intensive care unit (ICU) were collected, and the indicators such as Acute Physiology And Chronic Health Evaluation II (APACHE II) score, Sequential Organ Failure Assessment (SOFA) score, oxygenation index, and echocardiographic indicators within 24 hours of patients' admission to the ICU were recorded. The clinical data of the two groups of patients were compared. The correlation between indicators was analyzed by using Pearson or Spearman rank correlation method. A receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive performance of MIF, IL-18, and their combination for 28-day death in septic patients. Multivariate Logistic regression analysis was used to screen independent risk factors for 28-day death in septic patients, and a nomogram model was constructed. The discrimination, calibration, and clinical utility of the model were evaluated using ROC curve, calibration curve, and decision curve analysis (DCA).
RESULTS: A total of 63 septic patients were finally enrolled in the study, including 23 patients in the SIMI group and 40 patients in the non-SIMI group. The APACHE II score, alanine aminotransferase (ALT), aspartate aminotransferase (AST), N-terminal pro-brain natriuretic peptide (NT-proBNP), cTnI, MB isoenzyme of creatine kinase (CK-MB), IL-18, and MIF were all higher in the SIMI group compared to the non-SIMI group (all P<0.05). There were no statistically significant differences in demographic data, other laboratory indicators, and echocardiographic parameters between the two groups. Correlation analysis revealed a positive correlation between MIF and downstream inflammatory factor IL-18 and APACHE II score in septic patients (r values were 0.523 and 0.556, respectively, both P<0.05). Among echocardiographic indicators, MIF was negatively correlated with left ventricular ejection fraction (LVEF; r=-0.265, P<0.05), while there was no significant correlation between MIF and left ventricular posterior wall thickness at end-diastole or left atrial diameter at end-diastole (both P>0.05). ROC curve analysis revealed that both MIF and IL-18 possessed predictive value for 28-day death in septic patients [the area under the ROC curve (AUC) and 95% confidence interval (95%CI) were 0.745 (0.563-0.933) and 0.751 (0.614-0.892), respectively], and the combined prediction of the two had an AUC of 0.784 (95%CI was 0.629-0.940), with a sensitivity of 78.6% and a specificity of 79.6%. Multivariate Logistic regression analysis revealed that an elevated SOFA score [odds ratio (OR)=1.381, 95%CI was 1.067-1.787, P=0.014], increased IL-18 (OR=1.000, 95%CI was 1.000-1.001, P=0.023), elevated MIF (OR=1.000, 95%CI was 1.000-1.000, P=0.036), and decreased oxygenation index (OR=0.989, 95%CI was 0.978-1.000, P=0.046) were independent risk factors for 28-day death in patients with sepsis. Based on these variables, a nomogram model for predicting 28-day death in septic patients was constructed. ROC curve analysis indicated that the AUC of the nomogram model for predicting 28-day death in septic patients was 0.894 (95%CI was 0.766-1.000). Further analysis revealed that the model's C-index reached 0.894, and both the calibration curve and DCA curve suggested good discriminatory power, calibration capability and clinical utility of the model.
CONCLUSIONS: MIF can serve as a sensitive biomarker for early identification of SIMI, and the combined detection of MIF and IL-18 can enhance the predictive efficacy of prognosis for sepsis patients.
参考来源
- Guo W, Ma L, Wang Y, et al. [Correlation analysis of macrophage migration inhibitory factor with related markers of septic myocardial injury and its prognostic predictive value]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42563679. doi:10.3760/cma.j.cn121430-20260106-00010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。